ClinConnect ClinConnect Logo
Search / Trial NCT04574037

Prediction of Post-stroke Motor Recovery

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 28, 2020

Trial Information

Current as of November 09, 2025

Recruiting

Keywords

Stroke Motor Prediction

ClinConnect Summary

This clinical trial is studying how to predict recovery of movement in the arm after a stroke. Understanding how well a person might recover is important for informing them and their families about their options for care, such as whether they might go home or need rehabilitation. The trial will test a new prediction tool called "PREP-UCV," which builds on an existing tool that has successfully predicted recovery for about 75% of patients. The study aims to confirm this tool’s accuracy by looking at factors like age and specific medical scores to see how well it can predict recovery for patients within three months of having a stroke.

To participate in this study, individuals must be at least 18 years old and have been admitted to the stroke unit at Pitié-Salpêtrière hospital with arm movement difficulties due to a stroke. Participants will undergo some assessments, including MRI scans and other tests, to help researchers gather the necessary information. The goal is to improve understanding of stroke recovery and tailor rehabilitation programs to better meet patients' needs. If you or someone you know fits these criteria and is interested in participating, this study could provide valuable insights into post-stroke recovery.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • age ≥ 18 y-o,
  • admitted in the Pitié-Salpêtrière stroke unit,
  • stroke with a upper limb motor deficit,
  • agree to participate;
  • Exclusion criteria:
  • contra-indication to MRI or TMS,
  • patients under legal guardianship ,
  • patients without healthcare insurance

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials